Vaccine News and Research

Latest Vaccine News and Research

IRX Therapeutics raises $8M to further develop pipeline of cancer vaccine candidates

IRX Therapeutics raises $8M to further develop pipeline of cancer vaccine candidates

Meningococcal disease in infants: A potentially difficult and serious diagnosis

Meningococcal disease in infants: A potentially difficult and serious diagnosis

Soligenix signs common stock purchase agreements with existing and new investors

Soligenix signs common stock purchase agreements with existing and new investors

Minapharm Pharmaceuticals acquires 95% of the share capital of ProBioGen

Minapharm Pharmaceuticals acquires 95% of the share capital of ProBioGen

FDA unveils safety reports on recently approved drugs, biologics

FDA unveils safety reports on recently approved drugs, biologics

Microneedle skin patches as effective as hypodermic needles for flu vaccination

Microneedle skin patches as effective as hypodermic needles for flu vaccination

Vaccination against 2009 H1N1 influenza virus may also protect against 1918 Spanish influenza virus

Vaccination against 2009 H1N1 influenza virus may also protect against 1918 Spanish influenza virus

Acclaimed virologist delivers the 2010 Leeuwenhoek prize lecture

Acclaimed virologist delivers the 2010 Leeuwenhoek prize lecture

Cyntellect to provide LEAP Cell Processing Workstation to Salk Institute for Biological Studies

Cyntellect to provide LEAP Cell Processing Workstation to Salk Institute for Biological Studies

Alexion's Soliris may benefit patients with thrombotic microangiopathy from uncontrolled complement activation

Alexion's Soliris may benefit patients with thrombotic microangiopathy from uncontrolled complement activation

Inovio commences immunization in U.S. Phase I clinical trial of SynCon H5N1 influenza DNA vaccine

Inovio commences immunization in U.S. Phase I clinical trial of SynCon H5N1 influenza DNA vaccine

First patient treated in multicentre Phase I clinical trial of SCIB1 DNA ImmunoBody vaccine for melanoma

First patient treated in multicentre Phase I clinical trial of SCIB1 DNA ImmunoBody vaccine for melanoma

New research evaluating substantial disease burden of PNH presented at European Hematology Association

New research evaluating substantial disease burden of PNH presented at European Hematology Association

Monoclonal antibodies induce long-lasting, protective antiviral immune response

Monoclonal antibodies induce long-lasting, protective antiviral immune response

Children get MRI tests for reasons unrelated to benign anomalies: Study

Children get MRI tests for reasons unrelated to benign anomalies: Study

ARCA receives approval to commence enrollment of first therapeutic trial using HIV vaccine candidate

ARCA receives approval to commence enrollment of first therapeutic trial using HIV vaccine candidate

Scientists manipulate simple bacteria into constructing internal compartments for biofuels, vaccines

Scientists manipulate simple bacteria into constructing internal compartments for biofuels, vaccines

Researchers transform yellow fever vaccine to fend off mosquito borne parasites that cause malaria

Researchers transform yellow fever vaccine to fend off mosquito borne parasites that cause malaria

Capitol Hill briefing addresses neglected tropical diseases

Capitol Hill briefing addresses neglected tropical diseases

ACIP's new immunization guidelines for upcoming year

ACIP's new immunization guidelines for upcoming year

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.